Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Andhra University inks two Memoranda of Understanding with Survey of India and Aurobindo Pharma

by Team Small News | Dec 2, 2025 | Aurobindo Pharma, Pharma

Andhra University in Visakhapatnam (Vizag) has taken a significant step towards enhancing student employment and research opportunities by signing two memoranda of understanding (MoUs) with the Survey of India and Aurobindo Pharma Foundation. The agreements aim to...

Andhra University Signs Two Memoranda of Understanding to Foster Research and Employment Opportunities

by Team Small News | Dec 1, 2025 | Aurobindo Pharma, Pharma

Andhra University (AU) has taken a significant step towards enhancing its research capabilities and improving student employability by signing two Memorandums of Understanding (MoUs) with Aurobindo Pharma Foundation and the Survey of India. The partnerships aim to...

Aurobindo Pharma makes significant investment in injectables, readjusts capital expenditure, and outlines Merck-CDMO partnership strategy in new video coverage of market trends.

by Team Small News | Nov 22, 2025 | Aurobindo Pharma, Pharma

In an exclusive interview with ET Now, V Murlidharan, the CEO of Aurobindo Pharma’s Europe business, shared insights into the company’s success. According to Murlidharan, the key factors contributing to the company’s growth are the expansion of its...

Aurobindo Pharma’s Rajasthan-based facility receives 9 observations from the US FDA.

by Team Small News | Nov 16, 2025 | Aurobindo Pharma, Pharma

Aurobindo Pharma, a leading pharmaceutical company, has received nine observations from the US Food and Drug Administration (USFDA) for its facility in Rajasthan, India. The USFDA had conducted an inspection of the facility from January 27 to February 5, 2020. The...

Invest in Aurobindo Pharma with a projected target price of Rs 1350, as recommended by Motilal Oswal.

by Team Small News | Nov 12, 2025 | Aurobindo Pharma, Pharma

Motilal Oswal has recommended a “buy” rating for Aurobindo Pharma, with a target price of Rs 1350. The brokerage firm is optimistic about the company’s future prospects, driven by its strong product pipeline, increasing presence in the US market, and...

Aurobindo Pharma’s consolidated net sales for September 2025 stood at Rs 8,285.70 crore, marking a 6.28% year-over-year increase.

by Team Small News | Nov 7, 2025 | Aurobindo Pharma, Pharma

Aurobindo Pharma, a leading pharmaceutical company, has released its consolidated financial results for the quarter ended September 2025. The company’s net sales for the quarter stood at Rs 8,285.70 crore, representing a year-over-year (Y-o-Y) growth of 6.28%....
« Older Entries

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress